Put this in your pipe and smoke it: Donald Trump just legalized marijuana across the US. As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government. On Thursday, it finally happened. He signed an executive order to “reclassify” weed to a “Schedule III” drug – throwing it into the same category as codeine-laced Tylenol, testosterone and anabolic steroids. That’s ...

文章核心观点 - 特朗普总统签署行政命令 指示联邦机构将大麻从《管制物质法案》的附表I重新分类至附表III 这被视为行业长期寻求的监管里程碑 可能显著重塑大麻监管框架并承认其医疗用途 [1][2][11] - 行政命令强调大麻的合法医疗用途 但明确指出其并未以任何形式将大麻合法化 也未批准其作为娱乐性药物使用 [5][11] - 此举可能减轻行业税负 改善研究条件并提升行业信誉 但并非最终改革 其实际影响取决于机构行动速度、法规实施情况以及国会是否跟进 [8][11][13] 行政命令内容与性质 - 行政命令是总统发布的正式书面指令 要求联邦政府在现有法律下采取特定行动 其本身并非立法 不能创建新法或推翻国会通过的法令 [2][3] - 命令指示相关机构推进将大麻重新分类至《管制物质法案》附表III [2] - 目前大麻被列为附表I物质 与海洛因和LSD并列 被认为无公认医疗用途且滥用风险高 重新分类至附表III后 大麻将与氯胺酮和睾酮等药物同属一类 这些药物被认可具有医疗用途且滥用风险较低 [4] 对行业的具体潜在影响 - 重新分类可能消除国税局280E条款的适用 该条款目前阻止大麻企业扣除大部分运营费用 这一变化可能实质性改善整个行业的盈利能力 [8] - 正式的医疗认可可能加速临床研究 扩大医生接受度 并增强机构投资者的信心 [8] - 行政命令还为大麻二酚带来潜在重要进展 根据医疗保险和医疗补助服务中心正在评估的新模式 某些基于CBD的产品最早可能在2026年4月有资格获得医疗保险覆盖 [5] - 命令还敦促国会重新考虑更新“最终大麻衍生大麻素产品”的定义 以确保患者能够获得全谱CBD [6] 市场反应与行业现状 - 该消息已重新点燃投资者的热情 一些热门大麻股如Tilray Brands、Canopy Growth Corporation和Curaleaf Holdings在近期交易中录得强劲涨幅 [12] - 行业参与者多年来一直游说将大麻从附表I中移除 认为该分类阻碍了科学研究 加重了税收负担 并限制了对传统银行和资本市场的访问 [7] 重新分类的局限性 - 行业专家警告 行政命令可能不如市场最初希望的那么具有变革性 重新分类本身并未在联邦层面将大麻合法化 也未解决州与联邦法律之间持续存在的冲突 [9] - 根据附表III 大麻的获取将严格限于医疗和处方用途 并未为娱乐合法化、州际贸易或无限制的消费者销售提供途径 [9] - 最终影响仍取决于机构行动的速度、法规实施的方式以及国会是否跟进这些变化 这一领域的进展历来并不均衡 [13]

President Trump has signed an executive order to reclassify marijuana from a schedule one to a schedule three drug. While not making it fully legal, it would ease federal restrictions. Joining us right now with what this means for the marijuana industry and personal consumption is Kevin Sabbat.He is the CEO of Smart Approaches to Marijuana, a former White House Drug Policy Advisor, and he's the author of One Nation Under the Influence. Kevin, first of all, thank you uh for being here. It's been a while sinc ...

U.S. President Donald Trump on Thursday said he would sign an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy. ...

Marijuana Penny Stocks to Watch With Policy Shifts and High VolumeThe U.S. cannabis market continues building momentum as December trading heats up. Sales are projected to approach $45 billion in 2025, and analysts still expect double-digit annual growth through 2030. More states now support recreational access, and medical adoption continues expanding nationwide. Recently, headlines reported that President Trump may issue an executive order to shift cannabis from Schedule I to Schedule III. That change wou ...

Top Marijuana Stocks That Can Make You Money In 2026Much of the talk surrounding marijuana stocks trading better is based on new reform. Right now, many are waiting to see what Donald Trump will do regarding making cannabis a Class 3 substance. This news has set the cannabis sector ablaze. Right now, people are focusing on how to take advantage of this and make a profit. With a new year around the corner, using speculation on reform measures is a strategy some will take towards making a profit.Often, when n ...

Terms of Use Privacy Notice Accessibility About Us Reviews Site Map Your Ad Choices Advertising Contact us IBD Stock Charts IBD Stock Checkup Stock Quotes Stock Market Today The Big Picture My Stock Lists IBD Live Leaderboard SwingTrader MarketSurge IBD Digital MarketDiem The Wall Street Journal Barron's MarketWatch Dow Jones Smart Money Connect With Us On stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any speci ...

The company and many of its peers saw dramatic lifts on the back of new Presidential remarks.Investors caught quite the serious buzz from marijuana stocks on Tuesday, thanks largely to President Trump's strongest indication so far that he will get the ball rolling on the drug's rescheduling. One title that wafted well higher in price was Curaleaf Holdings (CURLF +23.18%), which was up by almost 25% when the smoke cleared. Will the Trump card be played?This came in an answer to a reporter's question whether ...

For hardly the first time in recent days, investors have become excited about the prospect of a significant change in U.S. drug laws.Will he or won't he? This is the question that's been front of mind for many marijuana stock investors over the past few days, as both credible media reports and President Trump himself fueled speculation that he will begin the process of decriminalizing the drug. Comments from the President late Monday injected new bullishness into weed stocks the following day. Sector mainst ...

After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease. ...